The Technical Analyst
USA Equities Corp. [USAQ]
Exchange: PNK Industry: Health Information Services
USA Equities Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0910
America/New_York / 3 mai 2024 @ 09:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.930 mill |
| EPS: | -0.0500 |
| P/E: | -1.820 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 10.22 mill |
| Avg Daily Volume: | 0.0183 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.820 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.820 | industry: PE -7.02 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0660 - 0.116 ( +/- 27.47%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2020-09-30 | Grogan Troy James | Sell | 88 016 | Convertible Note $88,016 |
| 2020-02-27 | Grogan Troy James | Buy | 1 | Convertible Promissory Note |
| 2020-02-20 | Grogan Troy James | Sell | 0 | Common Stock |
| 2019-09-01 | Grogan Troy James | Sell | 5 400 460 | Series A Preferred Stock |
| 2009-10-09 | Grogan Troy James | Sell | 76 000 000 | Convertible Note $76,000 |
| INSIDER POWER |
|---|
| 0.00 |
| Last 9 transactions |
| Buy: 1 | Sell: 82 149 614 |
Forecast:
11:25 - $0.100
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0910 (0.00% ) |
| Volume | 0.0314 mill |
| Avg. Vol. | 0.0183 mill |
| % of Avg. Vol | 172.07 % |
| Signal 1: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For USAQ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
USAQ
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. The company was incorporated in 1983 and is based in West Palm Beach, Florida.
Latest Press Releases
2024-05-02 08:30:00 - Press Release
Qhslab, Inc. Enhances Leadership Team With Dr. Marcos Sanchez-gonzalez As New Vp Of Medical And Scientific Affairs
West palm beach, fl, may 02, 2024 (globe newswire) -- qhslab, inc. (the "company") (otcqb: usaq), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced the appointment of dr. marcos sanchez-gonzalez as the new vice president of medical and scientific affairs.
2024-04-26 08:30:00 - Press Release
Qhslab, Inc. Announces Preliminary Unaudited First Quarter Revenue Results
West palm beach, fl, april 26, 2024 (globe newswire) -- qhslab, inc. ("the company") (otcqb: usaq), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based healthcare solutions, today announced its preliminary unaudited revenue for the first quarter ended march 31, 2024.
2024-03-28 08:00:00 - Press Release
Qhslab Announces Impressive 2023 Fiscal Year Results With Growing Revenues, Improved Gross Margins, And Substantial Reduction In Net Loss
West palm beach, fl, march 28, 2024 (globe newswire) -- qhslab, inc. (the “company”) (otcqb: usaq), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, today reported its financial and operational results for the fiscal year ended december 31, 2023. the year was marked by robust revenue growth, significant improvements in gross margins, and a strategic focus on expanding product lines and the company's customer base. moreover, the company significantly reduced its net operating loss, underscoring its enhanced operational efficiency and fiscal stewardship. the company's forward-thinking approach to integrating software solutions into the healthcare sector has propelled a substantial advancement in its financial and operational performance.
2024-01-30 08:30:00 - Press Release
Qhslab Integrates Digital Medicine Assessments Into Prominent Electronic Health Record (ehr) Company
This integration allows qhslab access to more than 160,000 providers that are the exact match for target providers. west palm beach, fl, jan. 30, 2024 (globe newswire) -- qhslab, inc. (the “company”) (otcqb: usaq), a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through emerging digital health and point-of-care technologies, is proud to announce the seamless integration of its digital medicine assessments with one of the nation's top electronic health record (ehr) company.
2023-11-14 08:30:00 - Press Release
Qhslab, Inc. (usaq) Reports Third Quarter Financial Results
25% y-o-y revenue growth in q3 2023 compared to q3 2022 and 51% increase in gross profit. ● in q3 2023, qhslab generated $336,407 in revenues, reflecting a notable 25% year-over-year increase from the $269,323 reported in q3 2022.
Latest News
2021-10-19 08:30:00 - GlobeNewsWire
USA Equities Corp. Launches Q-Scale Product to Meet Growing Mental Health End Market Demand
West Palm Beach, FL, Oct. 19, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on providing clinicians with tools to profit from value-based healthcare solutions through the use of emerging digital technologies, today announced the launch of its proprietary Q-Scale, or Quality of Life, digital medicine assessment tool for screening patients potentially suffering from mental and emotional health-related issues.
2021-09-22 08:30:00 - GlobeNewsWire
USA Equities Corp. Issues Updated September 2021 Investor Presentation
West Palm Beach, FL, Sept. 22, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on increasing physician revenues through value-based healthcare solutions and physician-directed digital medicine, today announced that it added a comprehensive investor presentation to the Company's website highlighting USAQ's growth strategy, recent milestones, key accomplishments and detailed discussion of product technology and business model.
2021-09-09 09:10:00 - Accesswire
USAQ CEO Discusses Financial Improvements in Q2, Product Projections in Audio Interview with SmallCapVoice.com
AUSTIN, TX / ACCESSWIRE / September 9, 2021 / SmallCapVoice.com Inc. ('SCV') announces the availability of a new interview with Troy Grogan, CEO of USA Equities Corp. (OTCQB:USAQ) ('the Company'), who provides an update on the Company's second quarter financial results and projections for both current and future products. After a fantastic 2021 Q2 that increased revenue over 50% compared to 2021 Q1, Grogan reported that USAQ also raised $750,000 in growth capital to continue expanding its digital medicine and point of care testing footprint.
2021-07-15 07:30:00 - GlobeNewsWire
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
West Palm Beach, FL, July 15, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced preliminary second quarter financial results for the period ended June 30, 2021, reporting strong sequential growth on several fronts.
2021-06-29 07:30:00 - GlobeNewsWire
USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services
2021-05-20 08:30:00 - Accesswire
USA Equities Corp. (OTCQB:USAQ) Discusses its Digital Medicine as the Future of Healthcare in Audio Interview with SmallCapVoice.com
AUSTIN, TX / ACCESSWIRE / May 20, 2021 / SmallCapVoice.com Inc. ("SCV") announces the availability of a new interview with Troy Grogan, CEO of USA Equities Corp. (OTCQB:USAQ), to discuss the Company's digital medicine and virtual care platform designed to make healthcare encounters more efficient, cost-effective and comfortable for both the physician and patient. Speaking with SCV's Stuart Smith, Grogan outlined the five focal points that drive USAQ's business model and growth trajectory.
2021-05-13 08:30:00 - GlobeNewsWire
USA Equities Corp. Announces Investor Relations & Corporate Communications Team
West Palm Beach, FL, May 13, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced that it has engaged several firms in the area of corporate communications, investment community outreach and strategic partnering to further expand the Company's visibility and level of investor and corporate community engagement.
2021-02-17 08:00:00 - GlobeNewsWire
USA Equities Corp (USAQ) Announces Newest Advisory Board Members in First Quarter 2021
WEST PALM BEACH, FL, Feb. 17, 2021 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) is focused on enabling primary care physicians (PCP's) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease through reimbursable procedures. The Company announced today its newest appointments to the medical and scientific advisory board. Joining the team of leading researchers and medical experts is Björn Herman, MD, FACS, who serves as the Assistant Professor of Otolaryngology at the University of Miami Miller School of Medicine; Frank Lichtenberger, MD, Ph.D., Board Certified Internist, and Allergy Immunologist; Juan Escobar, MD...
2020-12-30 08:00:00 - GlobeNewsWire
“USA Equities Corp (USAQ), Announces Revenues of $120,000 for the 4th Quarter of 2020 and Projects Revenues in excess of $300,000 for the 1st Quarter of 2021
WEST PALM BEACH, FL, Dec. 30, 2020 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) announced today that its revenues for the fourth quarter of 2020 would be approximately $120,000 and that its revenues would exceed $300,000 in the first quarter of 2021.
2020-12-10 06:15:00 - GlobeNewsWire
USA Equities Corp. (USAQ) and AllergiEnd Announces Allergy Testing Kit Distribution ahead of COVID-19 Vaccine
West Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) -- While the recent and rapid development of Pfizer/BioNTech's COVID-19 vaccine is undoubtedly good news, Time Magazine reported that administering this vaccine to individuals with a history of severe allergic reactions is not recommended, according to a U.K. Regulator, as the United Kingdom is the first country to begin vaccinations. This news comes after two healthcare professionals, both with a history of anaphylactoid reactions, suffered adverse side effects to the vaccine. They have since recovered.